Using bone scans to check kidney function in cancer patients
Part of Cancer, Kidney & urinary clinical trials.
This study looks at whether a bone scan (a routine imaging test to check for cancer spread) can also give information about your kidney function. If you've had cisplatin chemotherapy, your kidneys may be affected, and this scan might help doctors monitor your kidney health without extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a cancer diagnosis and have been treated with cisplatin (a type of chemotherapy) that can affect the kidneys
- You have been scheduled for a bone scan as part of your cancer care
- You have recent blood test results showing your kidney function (creatinine level)
- You do not have a history of kidney failure
- You are not pregnant and have no other reason that would make a bone scan unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
This trial tests a special PET scan to see if it can better find leftover kidney cancer after surgery compared to a standard CT scan. You may qualify if you had kidney cancer surgery within the last 4-16 weeks and are at high risk of the cancer coming back.
This study uses a CT scan to estimate how strong a cancer-affected bone area is, helping doctors evaluate fracture risk and bone management. It is aimed at adults with bone lesions from several common cancer types.
This trial tests a special PET/CT scan using a new tracer to measure kidney function and predict how much kidney function will remain after surgery to remove part of a kidney. It may help doctors better plan surgery and manage your care.
This Phase 1 study tests whether a special PET/CT scan drug ([18F]PT2385) can help doctors see kidney cancer and related tumors. It may help guide diagnosis and treatment decisions, especially in people planning surgery or starting belzutifan.
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
Hear when a new Cancer Patients Treated by Nephrotoxic Chemotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.